Abstract Many patients with COVID-19 have thromboembolic complications that worsen their prognosis Herein, the authors propose a modified version of the CHA2DS2-VASc score, including 1 point for COVID-19, so that prophylaxis to protect against thromboembolic events would be indicated before the condition becomes severe The advantages of this modification would be prevention of the patientâ€™s condition worsening due to thromboembolic problems and reduction of the likelihood of a need for intensive care and mechanical ventilation, reducing mortality